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Abstract 
Esfenvalerate belongs to the pyrethroid group of insecticides which display significant selective 
toxicity against insects compared to mammalian species, nevertheless, they may pose health risks, 
especially in case of accidental exposure. The aim of the present study was to model the effect of 
acute, relatively high-dose exposure of the esfenvalerate-containing formulation Sumi-Alpha®. 
Eventual functional alterations in the central nervous system and in the gastrointestinal tract 
were studied on in vitro tissue preparations at different delays after intragastric administration to 
rats. Neuronal effects were characterized by field potential recording in cortical and hippocampal 
brain slices, while gastrointestinal effects were examined by analyzing the motility and excitabili- 
ty of isolated ileum segments. On the brain slices originating from esfenvalerate-treated animals, 
changes in excitability of both inhibitory and excitatory type could be observed. Voltage thre- 
sholds necessary to evoke responses in neocortex slices were elevated, and population spike am- 
plitudes were lower in hippocampal slices. However, epileptiform potentials with pronounced late 
components were also observed. A decreased long-term potentiation (LTP) could be seen in both 
brain areas after esfenvalerate treatment. Seizure susceptibility of the slices was not significantly 
altered, but tended to be somewhat higher in slices originating from treated rats. In ileum seg-
ments, both spontaneous and acetyl-choline (ACh)-elicited contractions were modified by treat-
ment. Esfenvalerate raised the amplitude of contractions in the low ACh concentration range. 
However, the solvent xylene also considerably contributed to the detected changes. We can con-
clude that a relatively high, single oral dose of Sumi-Alpha® exerted mild and temporary effects on 
the elementary brain functions and intestine functions of the rat. 
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1. Introduction 
Pyrethroids are widely used insecticides in agriculture, veterinary medicine and public health. They are the syn-
thetic analogues of pyrethrins, compounds extracted from Chrysanthemum flowers [1]. The pyrethroid group 
contains ester type molecules with a wide diversity concerning their exact chemical structure. Pyrethroids pre- 
sent higher insecticidal efficacy and environmental stability than their natural precursors. Esfenvalerate was reg- 
istered in 1986; it contains the most insecticidally active (S,S-) stereoisomer of fenvalerate in high percentage.  
Pyrethroid insecticides exert their effects mainly on the central nervous system, causing hyperactive poison-
ing symptoms. Their mechanism of action is the modification of the gating kinetics of voltage-gated sodium 
channels [2]. Voltage-gated sodium channels are responsible for action potential generation in most neurons and 
other electrically excitable cells, contributing to signal transmission [3] [4]. Normally, these channels remain 
open only for about 1 ms, before being inactivated, then closed. Voltage-clamp studies have shown that pyreth-
roids slow down both activation and inactivation kinetics of the channels, leading to depolarizing after potentials 
[5]. If a sufficient fraction of channels is modified, the after potential reaches the cell’s threshold for excitation 
and repetitive after discharges are produced which are in the background of the poisoning symptoms [6].  
Orally administered esfenvalerate is rapidly eliminated from the body [7]. Fenvalerate exposure, at a dose 
level which produces acute poisoning, does not lead to brain lesions [8]. Notwithstanding, more or less 
long-lasting functional changes may be induced by esfenvalerate intoxication.  
In case of an accidental ingestion of pyrethroids, aside from the central nervous system, the gastrointestinal 
tract is another primary target, being the site of absorption. Esfenvalerate may modify the regulation of intestine 
movements and secretory functions. The gut smooth muscle has a spontaneous myogenic activity; it is able to 
contract independently from the central nervous system. The regulation in the gut is assured by the enteric 
nervous system, containing whole reflex circuits [9]. Enteric neurons form two major plexuses, which lay be-
tween the gut muscle layers and the mesenteria. The myenteric plexus extends the entire length of the gut, and 
its role is rather motility coordination, while the submucous plexus, present only in the small intestine, plays an 
important role in secretory control [10]. In enteric neurons, more than 20 neurotransmitter types have been iden-
tified. Acetyl-choline (ACh) acting on nicotinic and muscarinic receptors exerts an excitatory effect on smooth 
muscle contraction both on the level of interneurons, motoneurons and smooth muscle cells [9].  
The aim of the present study was to test the effects of the pyrethroid insecticide esfenvalerate on a mamma-
lian model, the rat. To model a relatively high-dose, accidental exposure, a single dose corresponding to the 
quarter of the oral LD50 was administered intragastrically to the animals. Data were acquired at different delays 
after treatment (1 - 7 days) to provide some indications about the dynamics of the poisoning. The study focused 
on eventual functional alterations in the gastrointestinal tract and in the central nervous system. Gastrointestinal 
effects were studied by analyzing the motility and excitability of isolated ileum segments. Effects on the nervous 
system were studied using surviving brain slices. Extracellular electrophysiological recordings were performed 
in two brain regions, the somatosensory cortex and the hippocampus. Basic synaptic activity, synaptic plasticity 
and seizure susceptibility were analyzed. 
2. Materials and Methods 
2.1. Animal Maintenance and Treatment 
The experiments were performed on young adult, male Wistar rats (100 - 250 g, Toxi-coop Ltd., Budapest, 
Hungary). The experimental design had been approved by Eötvös Loránd University Animal Care Committee 
and by the Hungarian National Animal Health Care Authority. The rats were kept under a constant 12-h 
light/dark cycle at controlled temperature (22˚C ± 2˚C). Standard pellet food (Toxi-coop Ltd.) and tap water 
were available ad libitum.  
Rats were treated with Sumi-Alfa® by gavage. The commercial product (containing xylene as a solvent) was 
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diluted 5× in physiological salt solution (0.9 g NaCl in 100 ml distilled water), the applied active ingredient dose 
was 20 mg/bwkg (injected volume: 0.2 - 0.5 ml). There were two control groups which received physiological 
salt solution or the appropriate dose of solvent (xylene) dissolved in physiological salt solution. The treated an-
imals were sacrificed 1, 2 or 7 days after gavage (these will be referred to as “one-day, two-day and seven-day” 
groups for simplicity) and the “xylene” and “phys. salt” control animals 1 day after gavage. Animal numbers in 
different groups were: phys. salt control—8; xylene control—8; one-day—7; two-day—7; seven-day—8. 
2.2. Chemicals 
Sumi-Alpha 5-EC® was purchased from Sumitomo Chemical Co. Ltd., Japan. All other compounds were pur-
chased from Sigma-Aldrich Co., Budapest, Hungary. 
2.3. Electrophysiological Recording on Brain Slices 
Experiments were performed as it was detailed in earlier papers [11]. Shortly, after decapitation, the brain was 
quickly removed and coronal slices (400 µm thick) containing the somatosensory cortex and the hippocampus 
were cut with a vibratome (Electron Microscopy Sciences, Hatfield, USA). Slices were incubated at room tem-
perature for an hour in artificial cerebrospinal fluid (ACSF) oxygenated with carbogen and buffered with 
HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid and its sodium salt, pH 7.1 - 7.2), the composi-
tion of which was (in mM): 120 NaCl; 2 KCl; 1.25 KH2PO4; 2 MgSO4; 20 NaHCO3; 2 CaCl2; 10 glucose; 6.7 
HEPES—acid; 3.3 HEPES—Na.  
Slices were then placed into an interface type recording chamber (FST Ltd., North Vancouver, Canada), 
through which standard ACSF was perfused (2.5 ml/min). The composition of the ACSF solution was (in mM): 
126 NaCl; 26 NaHCO3; 1.8 KCl; 1.25 KH2PO4; 1.3 MgSO4; 2.4 CaCl2; 10 glucose (pH: 7.4). The solution was 
saturated with carbogen at 33˚C ± 1˚C.  
Electrical single-shock stimulation was used to elicit field excitatory postsynaptic potentials (fEPSPs) in the 
neocortex. Similarly, electrically evoked responses were recorded in the hippocampus, population spikes (POP- 
spikes) sitting on the EPSP curve were detected with extracellular glass microelectrodes (5 - 10 MΩ) filled with 
1 M NaCl. In case of the neocortical slices, the recording electrodes were positioned in the lower part of layer III 
of the neocortex and bipolar tungsten stimulation electrodes were positioned immediately below the recording 
electrodes at the border of the white and grey matter. In the hippocampal slices, stimulation electrodes were 
placed at the Schaffer collaterals and the recording electrodes into the stratum pyramidale of the CA1 region. 
The duration of the square voltage pulses was 100 µs (BioStim, Supertech Ltd., Pécs, Hungary). Signals were 
band-pass filtered (0.16 Hz - 1 kHz) and amplified 1000× (BioAmp, Supertech Ltd., Pécs, Hungary), A/D con-
verted and recorded with the SPEL Advanced Intrasys computer program (Experimetria Ltd., Budapest, Hun-
gary). 
Before recording, the viability of each slice was tested. If the peak-to-peak amplitude of the maximum evoked 
response was smaller than 1 mV, the slice was excluded from the experiments. Basic synaptic functions were 
tested by determining the voltage threshold of the evoked field potential (T), and then a stimulation intensity of 
2T was applied to record “test stimulation”. Test stimulation recording was followed by the induction of long- 
term potentiation (LTP) by repetitive stimulation in order to investigate long-term synaptic plasticity. The sti-
mulation parameters were as follows: intensity—2 T, frequency—100 Hz, duration—5 s, 4 times with 10 s 
breaks. Subsequently, test stimulation was carried out with 0.1 Hz during 30 min at 2 T. Finally, responses 
evoked by test stimulation were recorded (“after LTP”). On some neocortex slices, seizure susceptibility was 
tested by applying ACSF containing 20 µM 4-aminopyridine (4-AP) for 60 min. Spontaneous activity was rec-
orded with a paper chart recorder (Gould, Eichstetten, Germany), the latency time and frequency of seizure-like 
events was measured. Before and after perfusion with 4-AP, evoked test responses were also recorded (stimula-
tion intensity: 2 T).  
Stored signals were analyzed with the SPEL Advanced Intrasys computer program. In neocortical slices, at 
test stimulation intensity, characteristically an early (N1) and a late (N2) negative peak appeared following the 
stimulation, with a latency of 4 - 5 ms and 15 - 20 ms, respectively. The two negative peaks were usually sepa-
rated by a positive peak (P1). The amplitude of the early component of fEPSPs was measured as the peak-to- 
peak amplitude N1-P1 and the late component as the maximal peak of N2 (Figure 1(A)). In the hippocampal  
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Figure 1. (A) Original recordings of an electrically evoked field EPSP in a control neocortex slice; and (B) of a population 
spike sitting on the fEPSP in a control hippocampus slice; with analysis parameters displayed; (C) Spontaneous contractions 
of an isolated and suspended ileum segment; amplitude and tone of the contractions are displayed. Maximal contraction was 
evoked with KCl solution (indicated by arrow); (D) Cumulative administration of ACh (0.25, 0.5, 1, 2, 4 μM) to an ileum 
segment indicated by arrows.                                                                              
 
slices, the population spike amplitude (POPS) and the initial slope of the EPSP were evaluated (Figure 1(B)). 
The amplitude of an eventual second population spike evoked at a test stimulation intensity of 2 T was also 
measured. One-way ANOVA (with Levene’s test for homogeneity of variances and Tukey’s post-hoc test, p < 
0.05) was used for statistical analysis to estimate the differences between control and each treated group. Data 
are presented as means ± S.E.M. 76 neocortical and 37 hippocampal slices were tested, originating from 38 rats. 
2.4. Motility Recording on Ileum Segments 
After decapitation, the abdomen of the rats was opened and 1 cm long segments of the ileum were resected. The 
isolated ileum segments were suspended before the recording in an organ bath (Experimetria Ltd., Budapest, 
Hungary) containing oxygenated rat Tyrode solution at 39˚C for 30 minutes and were washed through with fresh 
solution every 15 minutes. The composition of the Tyrode solution was (in mM): NaCl 136.9; KCl 2.7; NaHCO3 
11.9; KH2PO4 0.32; MgSO4 0.98; CaCl2 1.8; glucose 5.5; pH 7.4. Under these conditions, suspended ileum 
segments displayed spontaneous rhythmic contractions. The tonicity and contraction amplitude (Figure 1(C)) of 
the longitudinal smooth muscle were recorded by a mechanosensor. Eight different concentrations (0.25; 0.5; 1; 
2; 4; 8; 16; 32 μM) of ACh were cumulatively added (Figure 1(D)). After the ACh series, washout was per-
formed, and then the maximal contraction of each segment was elicited with 0.25 M KCl. Relative amplitude 
and tonicity data were calculated as a fraction of this maximal contraction (Figure 1(C)). Contraction patterns 
were filtered (low-pass at 10 Hz) and amplified (Experimetria Ltd., Budapest, Hungary). For data recording and 
analysis, a home-developed software was used. 38 ileum segments originating from 38 rats were tested. For sta-
tistical analysis, the same methods as for brain slice experiments were used; data are plotted as means ± S.E.M. 
3. Results 
Altogether 32 animals were treated intragastrically with Sumi-Alpha® at a dose of 20 mg/bwkg which corres-
ponds to LD50/4. In case of 10 rats, severe choreoathetosis developed within 1 - 2 h after treatment, these animals 
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were euthanized. The other animals also showed signs of discomfort, but no specific symptoms. 
3.1. Basic Excitability of Brain Slices 
In neocortical slices, the stimulation voltage threshold values necessary to evoke fEPSPs were significantly 
higher in the one-day and two-day treated groups than in the xylene control group (Table 1). The early 
component of the fEPSP was slightly but not significantly increased by both xylene and esfenvalerate. The 
amplitude of the late component was significantly lower in the xylene group than in the phys. salt group, 
whereas it was significantly higher in the two-day treated group than in the xylene group (Figure 2).  
In case of the hippocampal slices, the stimulation threshold values did not differ significantly among the 
groups (Table 1). There was no difference among the EPSP slope values either. However, the population 
spike amplitude was significantly smaller in the two-day and seven-day treated groups than in the xylene 
control group. In contrast, the occurrence and amplitude of a second population spike was significantly 
higher in the seven-day esfenvalerate group than in the xylene group. This could be seen as a tendency in the 
two-day treated group as well (Figure 3).  
3.2. Plasticity in Brain Slices 
Long-term plasticity was tested by the induction of LTP, in neocortical slices, the early component of the fEPSP 
was increased by ca. 40% in the control groups after repetitive stimulation. In the one-day, two-day and sev-
en-day esfenvalerate-treated groups, this enhancement was somewhat smaller: 16%, 26% and 27%, respectively. 
These differences are, however, not significant compared to the control. In hippocampal slices, the increase of 
population spikes was 30% in the phys. salt control group and 45% in the xylene control group. The corres-
ponding value was 47%, 37% and 30% in the one-day, two-day and seven-day esfenvalerate-treated groups, re-
spectively. Thus, the seven-day treated group showed a significantly smaller enhancement than the xylene con- 
trol group (Figure 4). 
 
 
Figure 2. (A) Amplitude of early and late components of the evoked fEPSPs in neocortical slices. * denote significant dif-
ferences (p < 0.05); (B) Sample fEPSP recorded in a neocortical slice originating from a rat two days after esfenvalerate 
treatment. The late component is more prominent than in control slices.                                             
 
Table 1. Voltage threshold values necessary to evoke field EPSPs in neocortical and population spikes in hippocampal slices 
(in Volts, mean ± S.E.M.). * denotes significant differences compared to the xylene control group (p < 0.05).               
Treatment group Phys. salt control Xylene control One day after  esfenvalerate 
Two days after 
esfenvalerate 
Seven days after  
esfenvalerate 
Neocortex 1.94 ± 0.15 1.56 ± 0.13 2.16 ± 0.12* 2.16 ± 0.18* 1.87 ± 0.06 
Hippocampus 2.26 ± 0.11 2.61 ± 0.17 2.42 ± 0.19 2.49 ± 0.15 2.39 ± 0.16 
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Figure 3. (A) EPSP slope and amplitudes of first and second population spike in hippocampal slices. * denote significant 
differences (p < 0.05); (B) Sample trace recorded in a hippocampal slice originating from a rat seven days after esfenvalerate 
treatment. A big second and a small third population spike appeared after the first one.                                 
 
 
Figure 4. Long-term synaptic enhancement was characterized with induction of LTP. 
The amplitude ratio of evoked responses after/before repetitive stimulation is plotted 
for neocortex and hippocampus. * denotes a significant difference (p < 0.05).         
3.3. Seizure Susceptibility of Neocortical Brain Slices 
The slices treated for 60 min with 4-AP displayed spontaneous activity both of ictal (long, complex seizure epi-
sodes) and interictal (single discharges) type. Recordings were analyzed according to the following parameters: 
latency time of first spontaneous episode, latency of first ictal (seizure) episode, number of ictal and interictal 
episodes during the second 30 min of 4-AP perfusion. The convulsant increased the amplitude of both the early 
and late components of fEPSPs, though the degree of this increase did not differ significantly among the slices 
originating from control and esfenvalerate-treated rats. The quantity and parameters of the spontaneous activity 
were not clearly different, either. Unfortunately, the activity of individual slices in each group was considerably 
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different, leading to large error margins. The group examined two days after esfenvalerate treatment seems more 
susceptible than the others; spontaneous activity was more abundant and developed faster than in the other 
groups (Table 2).  
3.4. Motility Recording on Ileum Segments 
Cumulative administration of ACh first lead to an increase in amplitude of the contractions, but at higher con-
centrations (beginning from 1 µM), the contractions rather decreased. This can be explained by the fact that 
ACh also increases the baseline tension (tonicity) of the ileum segments which impairs their ability to contract 
and relax with high amplitude. For this reason, the recordings with 1 µM ACh and above are considered as not 
suitable for analysis of contraction amplitude and the data derived from these recording segments are omitted 
from the figure. Compared to the phys. salt control, xylene significantly increased the amplitude of baseline 
contractions (0 µM ACh), and both esfenvalerate (two-day group) and xylene increased contractions at low 
(0.25 and 0.5 µM) ACh concentrations (Figure 5). 
ACh dose-dependently increased the tonicity of ileum segments, there were no significant differences among 
the different treatment groups in this respect. The only significant difference was seen between the control and 
xylene group at the administration of 8 µM ACh; the tonicity of the xylene group was lower (Figure 6). 
4. Discussion 
The present study shows that the insecticide Sumi-Alpha® (active ingredient: esfenvalerate) causes some func-
tional changes in rat nervous system and intestine, when administered orally at a LD50/4 dose. Some of these 
changes lasted at least a week.  
Historically, pyrethroids were divided into two subclasses based on the intoxication syndromes they cause. 
Type I pyrethroids (which do not contain a cyano group on the α carbon atom) provoke the T (tremor) syndrome, 
while Type II pyrethroids (which contain a cyano group on the α carbon atom) cause choreoathetosis and saliva-
tion (CS syndrome). Traditionally, esfenvalerate belongs to the Type II group, but according to more recent stu-
dies, it has rather mixed Type I/II characteristics [12]. In our study, the animals that developed intoxication 
symptoms displayed first tremor and salivation, then writhing convulsions, so we observed all known acute 
signs of pyrethroid poisoning, reflecting nervous system hyperexcitation. However, as our aim was to explore 
the effects of relatively low-level exposure which does dot elicit quickly developing specific symptoms, these 
animals were excluded from the experiments.  
There are practically no available studies dealing with basic mammalian neuronal functions after in vivo ex- 
posure to pyrethroids. The molecular target of pyrethroids is the voltage-gated sodium channel; by modifying its 
 
Table 2. Effect of esfenvalerate treatment on the increase in field EPSPs and pattern of spontaneous activity evoked by per-
fusion with 4-amino-pyridine. Data are presented as mean ± S.E.M.                                                
Treatment group Phys. salt  control Xylene control 
One day after  
esfenvalerate 
Two days after  
esfenvalerate 
Seven days after 
esfenvalerate 
Increase of early  
component [%] 45.9 ± 10.1 55.9 ± 15.3 29.9 ± 19.1 62.2 ± 12.9 53.8 ± 9.6 
Increase of late  
component [%] 147.3 ± 51.1 494.9 ± 263.5 200 ± 86.1 101.6 ± 38.7 187.3 ± 106.7 
No. of slices with  
ictal activity 4/8 4/8 3/8 3/7 2/8 
Latency of first  
spontaneous activity [min] 18.58 ± 5.53 20.90 ± 5.27 26.36 ± 11.39 14.94 ± 5.39 16.77 ± 3.62 
Latency of first ictal  
activity [min] 28.80 ± 6.08 44.96 ± 7.89 28.97 ± 14.05 20.13 ± 10.50 36.75 ± 4.15 
No. of ictal episodes 2.88 ± 1.94 1.88 ± 1.55 2.43 ± 2.42 5.86 ± 5.59 0.88 ± 1.28 
No. of interictal episodes 12.88 ± 11.70 17.25 ± 16.54 1.25 ± 1.06 53.60 ± 20.41 27.14 ± 12.50 
Frequency of spontaneous 
episodes [1/min] 0.65 ± 0.12 0.96 ± 0.11 0.43 ± 0.03 2.30 ± 0.96 1.17 ± 0.37 
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Figure 5. Contraction amplitude of isolated ileum segments 
during cumulative administration of ACh into the organ bath, 
compared to maximal contraction elicited with KCl. * denotes a 
significant difference compared to the (phys. salt) control group 
(p < 0.05).                                            
 
 
Figure 6. Tonicity of isolated ileum segments during cumula-
tive administration of ACh into the organ bath, compared to the 
tonicity of maximal contraction elicited with KCl. * denotes a 
significant difference compared to the (phys. salt) control group 
(p < 0.05).                                            
 
kinetics, these compounds may cause the overexcitation or inhibition of neurons and muscle fibers. In case of in 
vitro administration, usually the inhibitory changes are predominant. In in vitro systems, it is more probable that 
the concentration of the pyrethroid reaches such a high level which already leads to the depolarization block of 
the neurons, inhibiting the creation and conduction of action potentials [13].  
On the other hand, behavioral studies examining the effects of pyrethroids are quite abundant. However, these 
results are not directly comparable with our experiments carried out on isolated neuronal circuits present in brain 
slices. Pyrethroids decrease activity level, impair motor functions and sensomotor integration [14]. It has also 
been shown that they impair certain learning and memory functions, e.g. spatial learning studied by the Morris 
water maze [15] or fear conditioning studied by stepdown test [16].  
When analyzing the functions of the brain slices originating from esfenvalerate-treated animals, changes of 
both inhibitory and excitatory type could be observed. One and two days after treatment, the voltage thresholds 
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necessary to evoke fEPSPs in neocortex slices was elevated, this suggests a decrease in the basic excitability of 
the cortex. In hippocampal slices, the population spike amplitudes were lower two and seven days after treat-
ment than in control slices. As for the hyperexcitatory signs, in neocortex slices, the late component of the 
fEPSPs was increased two days after treatment, while in hippocampal slices, the amplitude of the second popu-
lation spike was significantly increased seven days after treatment. The appearance of epileptiform potentials is 
not surprising, as high-dose type II pyrethroids evoke epileptic activity in mammals [17]. 
Seizure susceptibility of the slices (examined by administration of 4-AP) was slightly but not significantly al-
tered by esfenvalerate treatment of the animals. Convulsant susceptibility of the slices originating from treated 
animals tended to be somewhat higher, but the data showed very high variability. Exposure to pyrethroids leads 
to acute seizures which disappear after treatment within a few hours. Our recordings took place 1 - 7 days after 
treatment, when susceptibility might be little higher, bur spontaneous seizure activity is not expected any more.  
As for plasticity phenomena, a decreased LTP could be seen in both brain areas after esfenvalerate treatment. 
This alteration was significant in hippocampal slices seven days after treatment. LTP is considered as the synap-
tic basis for the storage of memory traces and pyrethroids have been shown to impair learning as mentioned 
above. 
The functioning of the brain slices originating from rats treated with xylene did not differ considerably from 
those treated with phys. salt solution. The only difference was that in neocortical slices, the late component was 
significantly smaller in the xylene control group than in the phys. salt control group. This may be due to chance, 
as solvents rarely have acute effects; they rather tend to change the active ingredient’s toxicity by changing its 
pharmacokinetic parameters. In a study comparing the toxicity of pure fenvalerate with a commercial compound 
containing organic solvent, higher toxicity of the latter was observed [18]. The adverse effects of xylene on 
nervous system rather occur at chronic exposure [19].  
Esfenvalerate is rapidly eliminated from the organism after oral exposure. In case of a lower dose (2.5 mg/kg) 
than that used by us, almost the whole amount of the chemical was cleared from the body of rats within 2 days; 
but traces were still detectable in adipose tissue 7 days after treatment [7]. In our study, we detected some altera-
tions in the hippocampus even 7 days after treatment (epileptiform populations spikes, diminished LTP); at this 
time point, probably there was no substantial amount of esfenvalerate present in the brain any more. The ob-
served changes may be the aftereffects of the acute alterations.  
Pyrethroid formulations may cause gastrointestinal symptoms, including diarrhea after accidental oral expo-
sure in humans [20] or experimental exposure in animals [21]. No data are available for ileum motility functions 
after in vivo exposure to pyrethroids. In vitro tests on isolated ileum segments revealed that in vitro application 
of pyrethroids may have a biphasic or antagonistic effect on electrically evoked or cholinergic contractions [22] 
[23].  
As for our ileum motility results, both spontaneous and ACh-elicited contractions were different in treated vs. 
control rats. The solvent, xylene and esfenvalerate increased the amplitude of contractions in the low ACh con-
centration range 2 days after treatment. In summary, it seems that the basic excitability and ACh sensitivity of 
the ileal longitudinal muscle and/or enteral neurons was shifted by Sumi-Alpha® treatment; but a considerable 
part of the effects is attributable to the solvent.  
5. Conclusion 
In conclusion, a relatively high, single oral dose of the esfenvalerate-containing pyrethroid insecticide Sumi- 
Alpha® exerted mild and temporary effects on the elementary brain functions and intestine functions of the rat. 
Although recently developed pyrethroids show a very good selective toxicity for insects over mammals, their 
application needs caution. In vitro test systems may be useful to reveal mild functional changes caused by dif-
ferent chemicals at a low level of exposure, which does not yet lead to specific poisoning symptoms or morpho-
logical alterations. 
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